NVO270917P00030000
NVO Sep 17 2027 30.00 Put
optionOPRA
EODOct 20, 2026
1.63USD-7.910%(-0.14)5Vol3,937OI
Loading…
Underlying
Underlying Price
$38.90
Type
Put
Strike
30
Expiration
Sep 17, 2027
DTE
328d
Moneyness
OTM
Intrinsic
$0.00
NVO 30 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | — | — | 0 | 0 |
| Oct 30, 2026 | 6d | $0.26 | +766.67% | 1 | 4 |
| Nov 6, 2026 | 13d | $0.06 | +200.00% | 6 | 21 |
| Nov 13, 2026 | 20d | $0.04 | -60.00% | 11 | 11 |
| Nov 20, 2026 | 27d | $0.03 | +0.00% | 21 | 3,347 |
| Nov 27, 2026 | 34d | — | — | 0 | 0 |
| Dec 18, 2026 | 55d | $0.06 | -40.00% | 34 | 8,657 |
| Jan 15, 2027 | 83d | $0.13 | -18.75% | 156 | 10,194 |
| Mar 19, 2027 | 146d | $0.48 | +0.00% | 7 | 2,363 |
| Jun 17, 2027 | 236d | $1.03 | -5.50% | 2 | 3,825 |
| Sep 17, 2027 | 328d | $1.63 | -7.91% | 5 | 3,937 |
| Dec 17, 2027 | 419d | $2.00 | -6.98% | 1 | 1,445 |
| Jan 21, 2028 | 454d | $2.05 | +0.00% | 21 | 1,724 |
| Jun 16, 2028 | 601d | $2.83 | -11.56% | 2 | 114 |
| Dec 15, 2028 | 783d | $3.29 | -6.00% | 1 | 181 |
| Jan 19, 2029 | 818d | $3.30 | -2.65% | 15 | 35 |
NVO Nearby Strikes · Sep 17, 2027
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 20 P | $0.35 | +16.67% | 10 | 68 | OTM |
| 22.5 P | $0.38 | -28.30% | 30 | 791 | OTM |
| 25 P | $0.73 | -13.10% | 71 | 110 | OTM |
| 27.5 P | $1.30 | +0.00% | 1 | 39 | OTM |
| 30 P | $1.63 | -7.91% | 5 | 3,937 | OTM |
| 32.5 P | $2.74 | -10.16% | 1 | 770 | OTM |
| 35 P | $3.05 | -4.39% | 4 | 1,837 | OTM |
| 37.5 P | $4.15 | -2.35% | 23 | 2,057 | OTM |
| 40 P | $5.35 | -3.60% | 1 | 4,074 | ITM |
| 42.5 P | $6.85 | -4.46% | 1 | 732 | ITM |
| 45 P | $8.77 | -4.47% | 2 | 269 | ITM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.